Qube Research & Technologies (QRT)’s AstraZeneca AZN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Sell	6,150 -3,100	-34%	-$583K	﹤0.01%	2352
2026 Q1	$1.82M	Sell	9,250 -8,600	-48%	-$1.66M	﹤0.01%	2230
2025 Q4	$3.28M	Sell	17,850 -9,450	-35%	-$1.66M	﹤0.01%	2002
2025 Q3	$4.19M	Buy	27,300 +15,100	+124%	+$2.29M	﹤0.01%	1861
2025 Q2	$1.71M	Buy	12,200 +7,850	+180%	+$1.1M	﹤0.01%	2262
2025 Q1	$639K	Sell	4,350 -19,550	-82%	-$2.83M	﹤0.01%	2459
2024 Q4	$3.13M	Buy	23,900 +7,200	+43%	+$1.01M	﹤0.01%	1703
2024 Q3	$2.6M	Buy	+16,700	New	+$2.7M	﹤0.01%	1672

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AZN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its AstraZeneca (AZN) stake by 1.7% in Q2 2026, selling an estimated $1.24M and leaving 375,473 shares worth $71.2M. The position accounts for 0.07% of the portfolio, ranked #382.

Qube Research & Technologies (QRT) first reported a position in AZN in Q1 2018 and has held it in 20 quarters since. The position peaked at $75.3M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Qube Research & Technologies (QRT) held 375,473 shares of AstraZeneca worth $71.2M as of Q2 2026.
Qube Research & Technologies (QRT) sold 6,575 AstraZeneca shares in Q2 2026, an estimated $1.24M.
AstraZeneca made up 0.07% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #382 holding.
Qube Research & Technologies (QRT) first reported a position in AstraZeneca in Q1 2018 and has held it in 20 quarters since.
Qube Research & Technologies (QRT)'s AstraZeneca position peaked at $75.3M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.